- Intended Audience: Pharmacists interested in precision medicine.
- UAN: 0012-0000-17-256-H04-P
- CE Hours: 2 General
- Price: $20.00
- Dates Available: 09/29/2017-09/29/2020
- Activity Type: Knowledge
This course will identify medications affected by multiple genes and summarize the clinical implications of genetic variability in pain management and psychiatry.
Not Just One Gene: Medications Affected by Variability in Multiple Genes
- Identify relevant medications and potential clinical effects of individual variability in multiple genes affecting drug metabolism.
- Develop strategies for integrating pharmacogenetic test results for multiple genes into clinical decision making.
Clinical Applications in Pain Management Pharmacogenetics
- Describe clinical implications of genetic variability in pain management.
- Discuss clinical, patient-specific, genetic, and other factors that inform drug therapy changes for select opioids.
- Summarize the steps of implementing pain management pharmacogenetics.
Clinical Applications in Psychiatry Pharmacogenetics
- Describe clinical implications of genetic variability in psychiatric pharmacotherapy.
- Discuss clinical, patient-specific, genetic, and other factors that inform drug therapy changes in psychiatry.
- Summarize the structure and characteristics of representative psychiatry pharmacogenetics implementations
The following speakers, reviewers, and planning committee members have disclosed that he/she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
Amber L. Beitelshees, Pharm.D, MPH
Assistant Professor of Medicine
Division of Endocrinology, Diabetes and Nutrition
University of Maryland School of Medicine
Laura B. Ramsey, Ph.D.
Assistant Professor,UC Department of Pediatrics
Cincinnati Children’s Hospital Medical Center
Scott Alexander Mosley, Pharm.D.
College of Pharmacy, University of Florida
Schedule of Activities
Review all course materials and pass post-test with 70% or more.
View recorded lectures, receive a 70% or higher on final exam and complete course evaluation.
- The University of Florida College of Pharmacy will report CPE credit to CPE Monitor and CE Broker when applicable. If you would like a paper statement of credit, you may print it from your NABP e-profile.
- All pharmacists and pharmacy technicians maintain their own license and/or certification and it is their responsibility to follow up with the Office of Continuing Education at the University of Florida if any CE credit discrepancies are found.
- It is at the University’s discretion to award or deny credit to a late claiming participant (i.e. after 60 days of the participant engaging in a CPE activity) as it is the University’s CE activity and the provider needs to ensure the requirements necessary for credit are successfully completed.
- The University may request access to CPE Monitor® if the activity in question occurred within the previous 6 months and with an appropriate reason for access, i.e. power outage, etc.
This course received no outside funding support.
Computer and Internet access are required to complete this course. Course content is provided via Canvas.
This course in its entirety is copyrighted by the University of Florida Continuing Pharmacy Education and may not be duplicated or reproduced for any other purpose without specific written permission.